FOLFIRINOX for Locally Advanced Pancreatic Cancer: The Need for Individualized Strategies.

Akdogan O; Sutcuoglu O; Tuzcu TU; Yazici O; Ozdemir N

doi:10.1200/JCO-25-01214

← 뒤로

FOLFIRINOX for Locally Advanced Pancreatic Cancer: The Need for Individualized Strategies.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2026 Vol.44(2) p. 129

Akdogan O, Sutcuoglu O, Tuzcu TU, Yazici O, Ozdemir N

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Akdogan O, Sutcuoglu O, et al. (2026). FOLFIRINOX for Locally Advanced Pancreatic Cancer: The Need for Individualized Strategies.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 44(2), 129. https://doi.org/10.1200/JCO-25-01214

MLA Akdogan O, et al.. "FOLFIRINOX for Locally Advanced Pancreatic Cancer: The Need for Individualized Strategies.." Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 44, no. 2, 2026, pp. 129.

PMID 41343750

DOI 10.1200/JCO-25-01214

같은 제1저자의 인용 많은 논문 (2)

Limitations in Study Design and Stratification in Phase II Stereotactic Radiosurgery Trial for Small Cell Lung Cancer Brain Metastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2026
Immunomodulatory Effect of First-Line Cisplatin Versus Carboplatin in Response to Second-Line Nivolumab Therapy in Metastatic Non-Small Cell Lung Cancer.
Cancer investigation 2026